Acquisitions jump in clinical trial operations in H2
The highest value acquisition in 2021 was the $12.3m acquisition of Vifor Pharma by CSL.
By
The highest value acquisition in 2021 was the $12.3m acquisition of Vifor Pharma by CSL.
ByOffering quick setup timelines, the Veeva RTSM solution has so far supported more than 175 trials with sites in 60…
Science 37, a digital clinical trial operating system developer, has agreed to go public via a definitive agreement to merge…
Mid-size CRO/CDMO Altasciences has acquired early-stage clinical research organisation (CRO) WCCT Global.